Sign Up to like & get
recommendations!
1
Published in 2022 at "Biomolecules"
DOI: 10.3390/biom13010052
Abstract: Butyrate, one of the major products of the gut microbiota, has played notable roles in diverse therapies for multiple tumors. Our study aimed to determine the roles of genes that modulate butyrate metabolism (BM) in…
read more here.
Keywords:
genes modulating;
hepatocellular carcinoma;
therapies hepatocellular;
clinical prognosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancers"
DOI: 10.3390/cancers12103049
Abstract: Since 2007, for patients with advanced- or intermediate-stage hepatocellular carcinoma (HCC) unsuitable for locoregional treatments and with preserved liver function, the multikinase inhibitor (MKI) sorafenib has been the worldwide standard of care [...].
read more here.
Keywords:
hepatocellular carcinoma;
novel therapies;
carcinoma;
therapies hepatocellular ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14030504
Abstract: Simple Summary Hepatocellular carcinoma (HCC) is one of the leading causes of cancer related death worldwide. Most patients present with incurable disease and the prognosis remains poor. Immunotherapy using immune checkpoint inhibitors has become standard…
read more here.
Keywords:
hepatocellular carcinoma;
novel cellular;
hcc;
cellular therapies ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232214117
Abstract: Hepatocellular carcinoma (HCC) remains one of the most common malignancies and the third cause of cancer-related death worldwide, with surgery being the best prognostic tool. Among the well-known causative factors of HCC are chronic liver…
read more here.
Keywords:
hepatocellular carcinoma;
targeted therapies;
review;
therapies hepatocellular ... See more keywords